Brian J Wentworth,Mary McGrath,Sahil Khanna,Craig Lammert
{"title":"Autoimmune Hepatitis and the Pathways and Targets for Therapies.","authors":"Brian J Wentworth,Mary McGrath,Sahil Khanna,Craig Lammert","doi":"10.14309/ajg.0000000000003163","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003163","url":null,"abstract":"","PeriodicalId":520099,"journal":{"name":"The American Journal of Gastroenterology","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicole J Kim,Philip Vutien,Joleen A Borgerding,Lauren A Beste,Muyi Li,Abbey Barnard-Giustini,Kay M Johnson,George N Ioannou
{"title":"Hepatic steatosis estimated by VCTE-derived CAP scores was associated with lower risks of liver-related events and all-cause mortality in patients with chronic liver disease.","authors":"Nicole J Kim,Philip Vutien,Joleen A Borgerding,Lauren A Beste,Muyi Li,Abbey Barnard-Giustini,Kay M Johnson,George N Ioannou","doi":"10.14309/ajg.0000000000003161","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003161","url":null,"abstract":"INTRODUCTIONThe Controlled Attenuated Parameter (CAP) score derived from vibration-controlled transient elastography (VCTE, i.e. Fibroscan®) is a well-validated marker of hepatic steatosis. It is unclear if CAP scores are associated with risks of liver-related outcomes or all-cause mortality.METHODSIn this retrospective cohort study, we identified 7,587 U.S. Veterans (2,689 with cured hepatitis C [HCV], 1,523 with alcohol-associated liver disease [ALD], 3,375 with metabolic dysfunction-associated steatotic liver disease [MASLD]) who underwent VCTE between 5/2015-12/2021. We followed patients for new hepatic decompensation, hepatocellular carcinoma (HCC), and death from the VCTE date until 1/1/2022. Multivariable Cox-proportional hazards regression was used to assess for the associations between CAP measurements and clinical outcomes, adjusting for age, sex, race/ethnicity, body mass index, Charlson Comorbidity Index, diabetes, liver disease etiology, liver stiffness measurements, and FIB-4, and was reported separately by disease etiology and advanced fibrosis status.RESULTSOver a median follow-up time of ∼1.9 years, hepatic steatosis (grades 1-3 vs. 0) was associated with a lower risk of death (aHR 0.70, 95% CI: 0.57-0.85). Among patients with MASLD, hepatic steatosis was associated with a lower risk of decompensation (aHR 0.54, 95% CI: 0.32-0.90) and death (aHR 0.52, 95% CI: 0.37-0.73). These associations persisted in subgroup analyses of patients with advanced fibrosis and without cirrhosis.DISCUSSIONAmong patients who underwent VCTE in clinical practice, the presence of substantial hepatic steatosis estimated by the CAP score was associated with lower all-cause mortality among all patients and lower risk of decompensation and death among those with MASLD.","PeriodicalId":520099,"journal":{"name":"The American Journal of Gastroenterology","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Luke T Chmielecki,Nathan Pham,Marisa Wu,Avneesh Gupta,Laura Chu,Paul C Schroy
{"title":"Inclusion of a Society-Endorsed Practice Guideline in Computed Tomography Reports Improves Post-Diverticulitis Colonoscopy Adherence.","authors":"Luke T Chmielecki,Nathan Pham,Marisa Wu,Avneesh Gupta,Laura Chu,Paul C Schroy","doi":"10.14309/ajg.0000000000003157","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003157","url":null,"abstract":"","PeriodicalId":520099,"journal":{"name":"The American Journal of Gastroenterology","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Circumferential En Bloc Esophageal Mucosal Sloughing and Esophageal Cast.","authors":"Hamid Ullah,Shou-Jiang Tang","doi":"10.14309/ajg.0000000000003150","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003150","url":null,"abstract":"","PeriodicalId":520099,"journal":{"name":"The American Journal of Gastroenterology","volume":"120 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Raising the Bar: Is Hepatocellular Carcinoma Surveillance Warranted for Patients With Alcohol-Associated Cirrhosis?","authors":"Andrew M Moon","doi":"10.14309/ajg.0000000000003123","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003123","url":null,"abstract":"","PeriodicalId":520099,"journal":{"name":"The American Journal of Gastroenterology","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142489730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Joy W Chang,Kelcie Brophy,Kerry A Ryan,Joel H Rubenstein,Evan S Dellon,Lauren P Wallner,Hyungjin Myra Kim,Raymond De Vries
{"title":"Treatment preference archetypes in eosinophilic esophagitis and their implications for therapy.","authors":"Joy W Chang,Kelcie Brophy,Kerry A Ryan,Joel H Rubenstein,Evan S Dellon,Lauren P Wallner,Hyungjin Myra Kim,Raymond De Vries","doi":"10.14309/ajg.0000000000003133","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003133","url":null,"abstract":"BACKGROUNDLittle is known about how patients make decisions about and prioritize, therapies and disease management in eosinophilic esophagitis (EoE). We aimed to systematically identify and characterize patient perspectives and attitudes that influence decision making for EoE management.METHODSTo understand the diverse attitudes and values of EoE patients, we designed a study using the Q-method. We iteratively developed 31 statements related to EoE disease management. Participants sorted statements by ranking from +4 (most agree) to -4 (most disagree). By-person factor analysis, using 2- and 3- factor rotation, revealed distinct preference archetypes.RESULTSThirty-four adults with EoE (mean age 40.9, 51.4% male, 82.9% White) were recruited from gastroenterology and allergy clinics from a single center. We identified two treatment-centered archetypes: Medication preference, driven by symptoms and the desire to minimize risk of complications, and Natural treatment preference, focusing on identifying trigger foods and diet adherence. Three-factor analysis revealed an additional archetype: Treatment ambivalent, a view of EoE as a mild and episodic (not chronic) disease with low priority to treat. Comparison by factor revealed 54% of those in the natural preference archetype were recategorized as treatment ambivalent, suggesting that they see natural treatment as a less complicated or milder strategy and may be at risk of nonadherence and reduced treatment uptake.CONCLUSIONSWe identified three distinct treatment preference archetypes among individuals with EoE, underscoring the need for personalized treatment strategies, especially for those favoring natural approaches but masking ambivalence, and may be at risk for nonadherence or loss to follow-up.","PeriodicalId":520099,"journal":{"name":"The American Journal of Gastroenterology","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142449300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Solitary Colonic Ganglioneuroma with Central Depression: A Rare Case with Unique Morphology.","authors":"Masachika Saino,Toshio Kuwai,Shiro Oka","doi":"10.14309/ajg.0000000000003142","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003142","url":null,"abstract":"","PeriodicalId":520099,"journal":{"name":"The American Journal of Gastroenterology","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142449302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francesco Calabrese,Andrea Pasta,Edoardo Vincenzo Savarino,Vincenzo Savarino,Edoardo Giovanni Giannini,Elisa Marabotto
{"title":"Expanding Insights on Ambulatory Reflux Monitoring: Future Directions and Clinical Integration.","authors":"Francesco Calabrese,Andrea Pasta,Edoardo Vincenzo Savarino,Vincenzo Savarino,Edoardo Giovanni Giannini,Elisa Marabotto","doi":"10.14309/ajg.0000000000003080","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003080","url":null,"abstract":"","PeriodicalId":520099,"journal":{"name":"The American Journal of Gastroenterology","volume":"77 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142449301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pojsakorn Danpanichkul,Kwanjit Duangsonk,Agnes Hy Ho,Passisd Laoveeravat,Chawinthorn Vuthithammee,Disatorn Dejvajara,Vitchapong Prasitsumrit,Thanida Auttapracha,Busara Songtanin,Panu Wetwittayakhlang,Rashid N Lui,Gursimran Singh Kochhar,Siew C Ng,Francis A Farraye,Karn Wijarnpreecha
{"title":"Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Females and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021.","authors":"Pojsakorn Danpanichkul,Kwanjit Duangsonk,Agnes Hy Ho,Passisd Laoveeravat,Chawinthorn Vuthithammee,Disatorn Dejvajara,Vitchapong Prasitsumrit,Thanida Auttapracha,Busara Songtanin,Panu Wetwittayakhlang,Rashid N Lui,Gursimran Singh Kochhar,Siew C Ng,Francis A Farraye,Karn Wijarnpreecha","doi":"10.14309/ajg.0000000000003143","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003143","url":null,"abstract":"OBJECTIVETo update the global burden of Inflammatory Bowel Disease (IBD) using data from the Global Burden of Disease (GBD) 2021.METHODSData from GBD 2021 were analyzed to assess the IBD burden.RESULTSIn 2021, there were 375,140 new cases and 3.83 million total cases of IBD. Elderly-onset IBD accounted for 11% of incidences. 167 countries increased IBD incidence rate, with rates rising in females (APC:+0.06%) and the elderly (APC:+0.14%) but stable in males and the overall population.CONCLUSIONWhile the global burden of IBD has decreased overall, it has increased in females and the elderly.","PeriodicalId":520099,"journal":{"name":"The American Journal of Gastroenterology","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142449305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}